UX007

A former failure in PhII, the go-go FDA says it’s ready to consider an accelerated shortcut for Ultragenyx’s UX007
Endpoints
Wed, 08/29/18 - 10:41 am
Ultragenyx
UX007
FDA
LC-FAOD
Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Endpoints
Thu, 03/23/17 - 09:24 am
Ultragenyx
clinical trials
UX007
Glut1 DS